Abstracts
Showing 851 abstracts.
Citation
Gwendolyn B. Scott, M.D. A Phase I Trial of Dideoxyinosine (ddI) in Pediatric HIV Infection: Cerebrospinal Fluid and Plasma Pharmacokinetics.Citation
Anne-Marie Duliege, M.D., M.S. Transplacental Transfer of rCD4-IgG Given One Week and Immediately Prior to Birth: Safety and Pharmacokinetics in HIV-1 Seropositive Pregnant Women and Their Newborn Infants.Citation
A. Kavanaugh-mchuch. Cardiac Abnormalities in a Multicenter Interventional Study of Children with Symptomatic HIV Infection.Citation
Howard Max Rosenblatt, M.D. Relationship of Age and Clinical Status to Expression of Lymphocyte Surface Markers in Symptomatic (p2) and Asymptomatic (p1) HIV Infected Children.Citation
N. Modi. Pharmacokinetics of rCD4IgG in HIV-1 Seropositive Children and Pregnant Women.Citation
Jashvant D. Unadkat, Ph.D. Does Pregnancy after the Pharmacokinetics of (ddI) in HIV-1 Infected Women.Citation
Joyce A. Korvick, M.D. Women's Participation in AIDS Clinical Trials Group (ACTG) Trials in the USA - Enough or Still Too Few?.Citation
T-Cell Activation and Neurodevelopmental Outcomes in Perinatally HIV-Infected Children.Citation
TLR8 Ligands Inhibit HIV Infection of Macrophages through a Vitamin D Dependent Mechanism Involving Autophagy.Citation
Laboratory abnormalities among HIV-exposed, uninfected infants: IMPAACT Protocol P1025.Study
P1025